Consequently, our investigations have focused on the function of T cells, and in particular CD4+ cells due to the known role of CRACR2A in their activation and also progressive selective CD4+ lymphopenia which was evident from the patient’s phenotype. The gene discussed is CRACR2A; the disease is lymphopenia.